Synthesis 2011(22): 3669-3674  
DOI: 10.1055/s-0030-1260223
PAPER
© Georg Thieme Verlag Stuttgart ˙ New York

A Library of Conformationally Restricted Saturated Heterocyclic Sulfonyl Chlorides

Sergey Zhersha,b, Volodymyr V. Buryanova,b, Oleksandr V. Karpenkoa, Oleksandr O. Grygorenko*a,b, Andrey A. Tolmacheva,b
a Enamine Ltd., Alexandra Matrosova Street, 23, Kyiv 01103, Ukraine
b Department of Chemistry, Kyiv National Taras Shevchenko University, Volodymyrska St. 64, Kyiv 01033, Ukraine
Fax: +380(44)5024832; e-Mail: gregor@univ.kiev.ua;
Further Information

Publication History

Received 14 July 2011
Publication Date:
14 September 2011 (online)

Abstract

An approach to the synthesis of conformationally restricted saturated heterocyclic sulfonyl chlorides is described. Being guided by the principle of diversity-oriented conformational restriction, a mini-library of saturated heterocyclic sulfonyl chlorides was designed and synthesized. The library consists of nine members that are derivatives of azetidine, pyrrolidine, and piperidine. These compounds were prepared in 19-88% total yields on multigram scale starting from the corresponding Cbz-protected amino alcohols.

    References

  • 2a Lovering F. Bikker J. Humblet C. J. Med. Chem.  2009,  52:  6752 
  • 2b Kingwell K. Nature Rev. Drug Discovery  2009,  8:  931 
  • 2c Nicholls A. McGaughey GB. Sheridan RP. Good AC. Warren G. Mathieu M. Muchmore SW. Brown SP. Grant JA. Haigh JA. Nevins N. Jain AN. Kelley B. J. Med. Chem.  2010,  53:  3862 
  • 2d Feher M. Schmidt JM. J. Chem. Inf. Comput. Sci.  2003,  43:  218 
  • 3 Mann A. In Practice of Medicinal Chemistry   3rd ed.:  Wermuth CG. Academic Press/Elsevier; Amsterdam: 2008.  p.363-379  
  • 4 Watanabe M. Kazuta Y. Hayashi H. Yamada S. Matsuda A. Shuto S. J. Med. Chem.  2006,  49:  5587 
  • 5a Cowell SM. Lee YS. Cain JP. Hruby VJ. Curr. Med. Chem.  2004,  11:  2785 
  • 5b Hruby VJ. Al-Obeidi F. Kazmierski W. Biochem. J.  1990,  268:  249 
  • 5c Shemyakin MM. Ovchinnikov YA. Ivanov VT. Angew. Chem., Int. Ed. Engl.  1969,  8:  492 
  • 5d Komarov IV. Grigorenko AO. Turov AV. Khilya VP. Russ. Chem. Rev.  2004,  73:  785 
  • 5e Soloshonok VA. Curr. Org. Chem.  2002,  6:  341 
  • 5f Cativiela C. Ordóñez M. Tetrahedron: Asymmetry  2009,  20:  1 
  • 5g Trabocchi A. Scarpi D. Guarna A. Amino Acids  2008,  34:  1 
  • 5h Grygorenko OO. Artamonov OS. Palamarchuk GV. Zubatyuk RI. Shishkin OV. Komarov IV. Tetrahedron: Asymmetry  2006,  17:  252 
  • 5i Radchenko DS. Kopylova N. Grygorenko OO. Komarov IV. J. Org. Chem.  2009,  74:  5541 
  • 5j Kotti SRSS. Timmons C. Li G. Chem. Biol. Drug Des.  2006,  67:  101 
  • 5k Lucet D. Le Gall T. Mioskowski C. Angew. Chem. Int. Ed.  1998,  37:  2580 
  • 5l Radchenko DS. Pavlenko SO. Grygorenko OO. Volochnyuk DM. Shishkina SV. Shishkin OV. Komarov IV. J. Org. Chem.  2010,  75:  5941 
  • 5m Mityuk AP. Denisenko AV. Dacenko OP. Grygorenko OO. Mykhailiuk PK. Volochnyuk DM. Tolmachev AA. Tetrahedron Lett.  2010,  51:  1790 
  • 5n The Quinolones   Andriole VT. Academic Press; San Diego: 2000.  p.655 
  • 5o Grygorenko OO. Radchenko DS. Volochnyuk DM. Tolmachev AA. Komarov IV. Chem. Rev.  2011,  in press
  • 6a Bogen SL. Arasappan A. Velazquez F. Blackman M. Huelgas R. Pan W. Siegel E. Nair LG. Venkatraman S. Doll R. Shih N.-Y. George Njoroge F. Guo Z. Bioorg. Med. Chem.  2010,  18:  1854 
  • 6b Wels B. Kruijtzer JAW. Garner KM. Adan RAH. Liskamp RMJ. Bioorg. Med. Chem. Lett.  2005,  15:  287 
  • 6c Giordano C. Nalli M. Paradisi MP. Sansone A. Lucente G. Spisani S. Farmaco  2004,  59:  953 
  • 6d de Bont DBA. Sliedregt-Bol KM. Hofmeyer LJF. Liskamp RMJ. Bioorg. Med. Chem.  1999,  7:  1043 
  • 6e Lowik DWPM. Liskamp RMJ. Eur. J. Org. Chem.  2000,  7:  1219 
  • 6f Carson KG. Schwender CF. Shroff HN. Cochran NA. Gallant DL. Briskin MJ. Bioorg. Med. Chem. Lett.  1997,  7:  711 
  • 6g Moree WJ. van der Marel GA. Liskamp RMJ. J. Org. Chem.  1995,  60:  5157 
  • 6h Moree WJ. van Gent LC. van der Marel GA. Liskamp RMJ. Tetrahedron  1993,  49:  1133 
  • 7a Giordano C. Sansone A. Masi A. Lucente G. Punzi P. Mollica A. Pinnen F. Feliciani F. Cacciatore I. Davis P. Lai J. Ma S.-W. Porreca F. Hruby V. Eur. J. Med. Chem.  2010,  45:  4594 
  • 7b Giordano C. Masi A. Pizzini A. Sansone A. Lucente G. Consalvi V. Chiaraluce R. Eur. J. Med. Chem.  2009,  44:  179 
  • Synthesis of 1a was also described in the patents, see:
  • 8a Miner JN, Chapman MS, Quart B, Adjei A, and Yu C. inventors; PCT Int. Pat. WO  2009/38974. 
  • 8b Carlson S. inventors; PCT Int. Pat. WO  2008/75070. 
  • Synthesis of 1c was described in the patents, see:
  • 9a Ting PC, Aslanian RG, Berlin MY, Boyce CW, Cao J, Mangiaracina P, McCormick KD, Mutahi MW, Rosenblum SB, Shih N.-Y, Solomon DM, Tom WC, and Zeng Q. inventors; PCT Int. Pat. WO  2003/103669. 
  • 9b Imazaki N, Kitano M, Ohashi N, and Matsui K. inventors; Eur. Pat.  EP 1403255. 
  • 10 Bull DJ, Maguire RJ, Palmer MJ, and Wythes MJ. inventors; U.S. Patent  6610707. Syntheses of 1e and 1g were described in a patent, see:
  • 11 Genari C. Ceccarelli S. Piarulli U. Montalbetti CAGN. Jackson RFW. J. Org. Chem.  1998,  63:  5312 
  • 12 Gruetter C. Alonso E. Chougnet A. Woggon W.-D. Angew. Chem. Int. Ed.  2006,  45:  1126 
  • 14 Michael FE. Sibbald PA. Cochran BM. Org. Lett.  2008,  10:  793 
  • Isolated yields are given in Scheme 3. In the case of 3b, the alkenes 8 and 9 were obtained as a mixture that was not separated. For spectral and physical data of 7-9, see:
  • 15a Beaulieu F. Beauregard L.-P. Courchesne G. Couturier M. Laflamme F. L’Heureux A. Org. Lett.  2009,  11:  5050 
  • 15b Schramm H. Pavlova M. Christoffers J. Hoenke C. Synthesis  2009,  1659 
  • 15c Kim S. Yoon J.-Y. Synthesis  2000,  1622 
  • 16a Brown HC. Prasad JVNV. Zee S.-H. J. Org. Chem.  1985,  50:  1582 
  • 16b Tomori H. Shibatani K. Ogura K. Bull. Chem. Soc. Jpn.  1996,  69:  207 
  • 16c Chang D. Feiten H.-J. Engesser K.-H. van Beilen JB. Witholt B. Li Z. Org. Lett.  2002,  4:  1859 
  • 16d Takeda K. Tsuboyama K. Hoshino M. Kishino M. Ogura H. Synthesis  1987,  557 
  • 16e Mazzini C. Lebreton J. Alphand V. Furstoss R. J. Org. Chem.  1997,  62:  5215 
  • 16f Sanchez-Sancho F. Herradon B. Tetrahedron: Asymmetry  1998,  9:  1951 
  • 16g Abreu AR. Costa I. Rosa C. Ferreira LM. Lourenco A. Santos PP. Tetrahedron  2005,  61:  11986 
  • 16h Boyer N. Jubault P. Quirion J.-C. Gloanec P. De Nanteuil G. Eur. J. Org. Chem.  2008,  4277 
  • 16i Hanselmann R. Johnson G. Reeve MM. Huang S.-T. Org. Process Res. Dev.  2009,  13:  54 
  • 17a Back TG. Nakajima K. Org. Lett.  1999,  1:  261 
  • 17b Norton TR. Seibert RA. Benson AA. Bergstrom FW. J. Am. Chem. Soc.  1946,  68:  1572 
  • 18 Sanchez JP. Domagala JM. Heifetz CL. Priebe SR. Sesnie JA. Trehan AK. J. Med. Chem.  1992,  35:  1764 
  • 19 Jones CA. Jones IG. Mulla M. North M. Sartori L. J. Chem. Soc., Perkin Trans. 1  1997,  2891 
  • 20 Rosenberg SH. Spina KP. Condon SL. Polakowski J. Yao Z. Kovar P. Stein HH. Cohen J. Barlow JL. Klinghofer V. Egan DA. Tricarico KA. Perun TJ. Baker WR. Kleinert HD. J. Med. Chem.  1993,  36:  460 
  • 21 Nicolaides ED. Tinney FJ. Kaltenbronn JS. Repine JT. DeJohn DA. Lunney EA. Roark WH. Marriott JG. Davis RE. Voigtman RE. J. Med. Chem.  1986,  29:  959 
1

MDL Drug Data Report; Elsevier MDL, version
2010.2/32.08.

13

A method analogous to that reported herein was disclosed in the patents; in particular, the syntheses of 1a and 1c on a gram scale were described (see ref. 8 and 9b).